We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
-9.55%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$307M
AUM Growth
-$58.7M
Cap. Flow
-$19.7M
Cap. Flow %
-6.42%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RNAC icon
Cartesian Therapeutics
RNAC
+$16.1M
2
CARM
Carisma Therapeutics
CARM
+$2.27M
3
TTOO
T2 Biosystems, Inc
TTOO
+$1.39M

Sector Composition

Rank Sector Weight
1 Healthcare 96.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCRB icon
1
Seres Therapeutics
MCRB
$48.1M
$126M 40.85%
634,144
– –
SYRS
2
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$58.4M 19.02%
480,666
– –
EDIT icon
3
Editas Medicine
EDIT
$399M
$56.1M 18.25%
3,455,316
– –
AGIO icon
4
Agios Pharmaceuticals
AGIO
$2.16B
$40.3M 13.11%
965,369
– –
RNAC icon
5
Cartesian Therapeutics
RNAC
$232M
$14.2M 4.61%
27,562
-27,500
-50% -$16.1M
TTOO
6
DELISTED
T2 Biosystems, Inc
TTOO
$10.3M 3.34%
390
-45
-10% -$1.39M
CARM
7
DELISTED
Carisma Therapeutics
CARM
$2.53M 0.82%
66,201
-51,535
-44% -$2.27M

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q4 2016 Portfolio in Review

As of Q4 2016, Flagship Pioneering held 7 positions worth $307M, down 16% from $366M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering withdrew a net $19.7M in Q4 2016, reducing 3 holdings. Its largest reduction was Cartesian Therapeutics, cutting an estimated $16.1M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier.

  • Flagship Pioneering's biggest Q4 2016 reduction was Cartesian Therapeutics, cutting an estimated $16.1M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $307M portfolio in Q4 2016.
  • Flagship Pioneering opened 0 new positions and closed 0 in Q4 2016.
  • Flagship Pioneering's portfolio value fell 16% quarter-over-quarter to $307M.

Based on Flagship Pioneering's 13F filing for Q4 2016, filed 13 Feb 2017.